Application Nr Approved Date Route Status External Links
NDA205422 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rexulti Is Indicated For: Adjunctive Treatment Of Major Depressive Disorder (Mdd) [See Clinical Studies (14.1) ] . Treatment Of Schizophrenia [See Clinical Studies (14.2) ] . Rexulti Is An Atypical Antipsychotic Indicated For: Use As An Adjunctive Therapy To Antidepressants For The Treatment Of Major Depressive Disorder (Mdd) ( 1 , 14.1 ) Treatment Of Schizophrenia ( 1 , 14.2 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Brexpiprazole BREXPIPRAZOLE ZINC84758479

Comments